Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis

American Journal of Hematology

Volumn 90, Issue 3, 2015, Pages 220-224

  Otrock, Zaher K ^a   Eby, Charles S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; DEXAMETHASONE; ETOPOSIDE; FERRITIN; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; METHOTREXATE; RITUXIMAB; STEROID; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTICLE; AUTOIMMUNE DISEASE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CAUSE OF DEATH; COMBINATION CHEMOTHERAPY; CYTOPENIA; ERYTHROPHAGOCYTOSIS; FEMALE; FERRITIN BLOOD LEVEL; FEVER; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; GENE MUTATION; GENETIC SCREENING; HEMOPHAGOCYTIC SYNDROME; HEPATOMEGALY; HUMAN; HYPERFERRITINEMIA; HYPERTRANSAMINASEMIA; HYPOALBUMINEMIA; IDIOPATHIC DISEASE; IMMUNE DEFICIENCY; INFECTION; KIDNEY FAILURE; LACTATE DEHYDROGENASE BLOOD LEVEL; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; MULTIPLE ORGAN FAILURE; ORGAN TRANSPLANTATION; OVERALL SURVIVAL; PARTIAL THROMBOPLASTIN TIME; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; RARE DISEASE; SEPSIS; STEROID THERAPY; TRIACYLGLYCEROL BLOOD LEVEL; VERY ELDERLY; ADOLESCENT; BACTERIAL INFECTIONS; BLOOD; COMPLICATION; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MIDDLE AGED; MYCOSES; NEOPLASMS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VIRUS DISEASES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BACTERIAL INFECTIONS; FEMALE; FERRITINS; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MIDDLE AGED; MYCOSES; NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; STEROIDS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VIRUS DISEASES;

EID: 84923083822     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23911     Document Type: Article

References (33)

1. George MR. Hemophagocytic lymphohistiocytosis: Review of etiologies and management. J Blood Med 2014;5:69-86.
2. Shabbir M, Lucas J, Lazarchick J, et al. Secondary hemophagocytic syndrome in adults: A case series of 18 patients in a single institution and a review of literature. Hematol Oncol 2011;29:100-106.
3. Joshi R, Phatarpekar A, Currimbhoy Z, et al. Haemophagocytic lymphohistiocytosis: A case series from Mumbai. Ann Trop Paediatr 2011;31:135-140.
4. Karras A. What nephrologists need to know about hemophagocytic syndrome. Nat Rev Nephrol 2009;5:329-336.
5. Henter JI, Horne A, Arico M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediat Blood Cancer 2007;48:124-131.
6. Gupta A, Tyrrell P, Valani R, et al. The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2008;51:402-404.
7. Chandrakasan S, Filipovich AH. Hemophagocytic lymphohistiocytosis: Advances in pathophysiology, diagnosis, and treatment. J Pediatr 2013;163:1253-1259.
8. Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Ann Rev Med 2012;63:233-246.
9. Lykens JE, Terrell CE, Zoller EE, et al. Perforin is a critical physiologic regulator of T-cell activation. Blood 2011;118:618-626.
10. Henter JI, Elinder G, Soder O, et al. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand 1991;80:428-435.
11. Parodi A, Davi S, Pringe AB, et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: A multinational multicenter study of thirty-eight patients. Arthritis Rheum 2009;60:3388-3399.
12. Okabe T, Shah G, Mendoza V, et al. What intensivists need to know about hemophagocytic syndrome: An underrecognized cause of death in adult intensive care units. J Intensive Care Med 2012;27:58-64.
13. Imashuku S, Kuriyama K, Sakai R, et al. Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: A report from the HLH study center. Med Pediatr Oncol 2003;41:103-109.
14. Weaver LK, Behrens EM. Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis. Curr Opin Rheumatol 2014;26:562-569.
15. Canna SW, Behrens EM. Making sense of the cytokine storm: A conceptual framework for understanding, diagnosing, and treating hemophagocytic syndromes. Pediatr Clinics North Am 2012;59:329-344.
16. Milner JD, Orekov T, Ward JM, et al. Sustained IL-4 exposure leads to a novel pathway for hemophagocytosis, inflammation, and tissue macrophage accumulation. Blood 2010;116:2476-2483.
17. Janka G. Hemophagocytic lymphohistiocytosis: When the immune system runs amok. Klinische Padiatrie 2009;221:278-285.
18. Li J, Wang Q, Zheng W, et al. Hemophagocytic lymphohistiocytosis: Clinical analysis of 103 adult patients. Medicine 2014;93:100-105.
19. Parikh SA, Kapoor P, Letendre L, et al. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc 2014;89:484-492.
20. Tiong IS, Lau MB, Toumoua S, et al. A case of hemophagocytic lymphohistiocytosis in a patient with chronic lymphocytic leukemia after treatment with fludarabine, cyclophosphamide, and rituximab chemotherapy, with autopsy findings. Case Rep Hematol 2012;2012:326053.
21. Fukaya S, Yasuda S, Hashimoto T, et al. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: Analysis of 30 cases. Rheumatology 2008;47:1686-1691.
22. Malbora B, Polat E, Akyuz SG. Hemophagocytic lymphohistiocytosis and pelger-huet anomaly associated with colchicine intoxication. Hematol Rep 2014;6:5356.
23. Ramos-Casals M, Brito-Zeron P, Lopez-Guillermo A, et al. Adult haemophagocytic syndrome. Lancet 2014;383:1503-1516.
24. Zhang K, Jordan MB, Marsh RA, et al. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood 2011;118:5794-5798.
25. Santoro A, Cannella S, Bossi G, et al. Novel Munc13-4 mutations in children and young adult patients with haemophagocytic lymphohistiocytosis. J Med Genet 2006;43:953-960.
26. Riviere S, Galicier L, Coppo P, et al. Reactive hemophagocytic syndrome in adults: A multicenter retrospective analysis of 162 patients. Am J Med 2014;127:1118-1125.
27. Allen CE, Yu X, Kozinetz CA, et al. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2008;50:1227-1235.
28. Lehmberg K, McClain KL, Janka GE, et al. Determination of an appropriate cut-off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2014;61:2101-2103.
29. Lin TF, Ferlic-Stark LL, Allen CE, et al. Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality. Pediatr Blood Cancer 2011;56:154-155.
30. Schneider EM, Lorenz I, Muller-Rosenberger M, et al. Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis. Blood 2002;100:2891-2898.
31. Takahashi N, Chubachi A, Kume M, et al. A clinical analysis of 52 adult patients with hemophagocytic syndrome: The prognostic significance of the underlying diseases. Int J Hematol 2001;74:209-213.
32. Kaito K, Kobayashi M, Katayama T, et al. Prognostic factors of hemophagocytic syndrome in adults: Analysis of 34 cases. Eur J Haematol 1997;59:247-253.
33. Delavigne K, Berard E, Bertoli S, et al. Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy. Haematologica 2014;99:474-480.